SciELO - Scientific Electronic Library Online

 
vol.23 número12Enfermedad tromboembólica venosa: análisis de 239 casosEstudio de utilización de Tenofovir DF en el tratamiento antirretroviral de gran actividad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Anales de Medicina Interna

versión impresa ISSN 0212-7199

Resumen

BATUECAS MOHEDANO, M.; CARBALLO ALVAREZ, F.  y  GARCIA MENENDEZ, L.. Follow-up of serum monoclonal gammopathy at Guadalajara Health Area. An. Med. Interna (Madrid) [online]. 2006, vol.23, n.12, pp.569-572. ISSN 0212-7199.

Objective: To study the clinical course of patients with a serum monoclonal protein at Guadalajara Health Area. Material and methods: Prospective study of 186 patients with a newly diagnosed monoclonal component. They have been collected during the years 1999 and 2000. Results: The cumulative transformation probability at 43 months was 4.99% for those patients whose monoclonal gammopathy was overlooked, and 2% at 23 months for patients with monoclonal gammopathy of undetermined significance. The cumulative probability of survival for patients with multiple myeloma was 66.7% at 21 months. The conditional mortality rate (patients/months) at 4 years due to haematological disease was 4.48x10-4 for overlooked patients, 0 for diagnosed of monoclonal gammopathy of undetermined significance and 1.388x10-2 for multiple myeloma diagnosed. Discussion: A non malignant M component must be followed up due to it could increase patients' survival rate in relation with transformation in malignant disease.

Palabras clave : Monoclonal gammopathy; Plasma cells dyscrasias; Electrophoresis; Multiple myeloma; Waldenström macroglobulinemia.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons